This is the first part of a two-part series on a recent examination of the cannabis-use profiles and risk-factors associated with smoking cannabis in people using cannabis with medical intent. Smoking cannabis is associated with exposure to harmful toxins and therefore is one of the greatest health risks related to cannabis use. This is an important consideration for people using cannabis with a medical intent. Therefore, we examined the differences in those who prefer smoking cannabis to other consumption forms for mental health.
Our methodology aimed to explore the differences in the personal characteristics, mental health status, and cannabis-use profiles of those who smoke cannabis versus consumed cannabis by vaporization or oral ingestion. We collected data on how cannabis was being used and indicators of mental health and wellbeing for 100 medical cannabis dispensary users.
Key insights:
1. Inhaled cannabis, and more specifically smoked cannabis, was the most popular route of consumption in this sample (47%).
2. Cannabis smokers have distinct patterns of use compared to other consumption forms:
- They had a greater preference for THC-dominant chemovars.
- They consumed more frequently.
- They used in a greater quantity compared to those who vaporized their cannabis.
3. Smoking cannabis was not associated with cannabis use disorder, but was associated with an increased prevalence of alcohol use disorder.
4. There was no association detected between any form of consumption and anxiety, depression, or bipolar disorder.
Click here to read the full article, and be sure to come back next week to read Part 2 for more takeaways from the study.
Dr. Caroline MacCallum is a specialist in internal medicine with expertise in complex pain and cannabinoid medicine. In addition to serving as an advisor to EO Care, she is a clinical instructor in the Department of Medicine; Adjunct Professor in the Faculty of Pharmaceutical Sciences program; and associate member in the Dept. of Palliative Care at the University of British Columbia. An avid researcher, Dr. MacCallum is primary author of Practical Considerations for Medical Cannabis Administration and Dosing, and assistant editor for Cannabinoids and Pain.
Here's where you can find Dr. Caroline MacCallum online:
- Instagram: @dr.carolinemaccallum
- Twitter: @camaccallum
- Facebook: Dr. Caroline MacCallum
- Linkedin: Dr. Caroline MacCallum, MD
- Website: https://drcarolinemaccallum.com/
Navigating a cancer diagnosis is one of the most difficult life challenges a person can face. Two-time cancer survivor and EO spokesperson Ethan Zohn says, “cancer is a disease that touches every part of you as a human being: mental, physical, social, spiritual. You’re always just looking for ways to make yourself feel better.”
Gabapentin and cannabis are two substances frequently used to help manage pain and a range of other health conditions. While gabapentin is primarily used to help treat nerve pain, seizures and shingles-related discomfort, cannabis is well known for its analgesic, anti-inflammatory and relaxation-inducing effects.
A growing body of research illustrates the untapped potential of cannabis for a range of medical uses, like helping to manage pain, stress, sleep and appetite. However, studies also indicate that alternative methods of intake are necessary to create consistent, repeatable effects and to reduce the risks associated with smoking cannabis. According to a scientific review by the Institute of Medicine, “the future of cannabinoid drugs lies not in smoked marijuana but in chemically defined drugs that act on the cannabinoid systems that are a natural component of human physiology.”
Get special offers, event invites and the latest on new care offerings and product releases.
Wise Use for All
© 2024 All rights reserved. Patents pending. EO Care, Inc.
